Veea Inc. (VEEA) director Helder Antunes resigned from the board effective immediately on October 8, 2026, and will continue as the company’s Executive Vice President and Chief Revenue Officer. Veea stated that his resignation was not the result of disagreements with management or the board about the company’s operations, policies, or practices.
Effective October 8, 2026, director Alan Black was appointed to the board’s Compensation Committee. After Antunes’s resignation, the board unanimously approved reducing its size to five members.
Veea Inc. appointed director Kanishka Roy to serve on its Audit Committee, effective October 6, 2026.
Veea Inc. received four unsecured loans from NLabs Inc., a principal stockholder and an affiliate of Veea’s Chief Executive Officer, on September 29, 2026: three notes with principal of $500,000 each and one note with principal of $150,000. The notes accrue interest at an annual rate of 10%, calculated using a 365-day year and actual days elapsed. Principal and accrued interest are payable upon the earlier of December 31, 2026, or demand by NLabs. Veea may prepay the notes in whole or in part without penalty at any time, and the proceeds are for working capital.
VEEA Inc. (VEEA) reported that it has signed a non-binding term sheet with NovaGen Group B.V. for a proposed business combination that would create NovaGen Health Networks, a global health platform combining Veea’s edge AI infrastructure and HealthLynx with NovaGen’s regenerative medicine and longevity services. The parties aim to sign a definitive agreement within the coming weeks, but the transaction is subject to due diligence, shareholder and regulatory approvals, and other closing conditions, and may not be completed. In a related press release, GeoNova Capital signed a term sheet to provide an initial US$10 million investment in the combined company, and Veea’s management cites internal projections and an independent valuation indicating an approximate $750 million value for the combined entity, with initial NovaGen Health Networks deployments targeted for Q4 2026.
Veea Inc. (VEEA) entered into related‑party financing and approved a significant capital structure change. On August 26, 2026, NLabs Inc., a principal stockholder and affiliate of Veea’s CEO, made three unsecured loans to Veea via Demand Promissory Notes totaling $1,150,000, bearing 10% annual interest and payable on the earlier of December 31, 2026 or demand; proceeds are for working capital.
The board approved a 1‑for‑20 reverse stock split of Veea’s common stock, with effectiveness at 4:30 p.m. Eastern Time on August 28, 2026 and split‑adjusted trading expected to begin August 31, 2026. Every 20 issued and outstanding common shares will convert into 1 share, with fractional shares rounded up. Public warrants will be adjusted so each warrant represents 1/20 of one common share at an exercise price of $230.00 per whole share, requiring 20 warrants to purchase one share. VEEA and VEEAW will continue trading on the Nasdaq Capital Market, and the common stock will receive a new CUSIP.
Veea Inc. (VEEA) reports two related-party financings and a senior leadership change. On July 30 and 31, 2026, principal stockholder NLabs Inc., an affiliate of Veea’s CEO, made unsecured loans of $500,000 and $100,000 to Veea, documented as Demand Promissory Notes. Each note bears 10% annual interest, calculated on a 365‑day basis, and is payable upon the earlier of December 31, 2026 or demand, with no prepayment penalty; proceeds are for working capital.
The board terminated Chief Financial Officer and Senior Vice President Randal Stephenson without cause effective July 31, 2026, and appointed Greg Deisher, currently Chief Operating Officer and Executive Vice President, as Acting Chief Financial Officer from that date. On August 11, 2026, Veea and Mr. Stephenson entered into a Separation Agreement providing three months’ gross salary paid over six months, retention of previously vested stock options, and customary accrued compensation and expense reimbursements.
Veea Inc. entered into an At Market Issuance Sales Agreement with Roth Capital Partners LLC, allowing Veea to issue and sell shares of its common stock from time to time through or to Roth as sales agent or principal. A prospectus supplement filed on August 13, 2026 covers sales of up to $4,353,000 of common stock (the Placement Shares) under an existing effective Form S-3 registration statement.
Roth will use commercially reasonable efforts to sell shares in transactions qualifying as an “at the market offering” under Rule 415. Veea controls the maximum amount to be sold and may set minimum sale prices. Either party may suspend sales or terminate the agreement on five days’ written notice, and the arrangement ends automatically once all Placement Shares are sold. Roth is entitled to 3.0% of the gross proceeds from each sale as compensation. Veea has no obligation to sell any shares and has agreed to provide indemnification and contribution to Roth against certain liabilities.
Veea Inc. is offering up to $4,353,000 of common stock in an at-the-market program under a sales agreement with Roth Capital Partners, which will receive a 3.0% commission on gross proceeds. Shares will be sold from time to time on Nasdaq at prevailing prices.
As of August 11, 2026, Veea had 62,214,156 common shares outstanding, with a hypothetical 34,575,059 shares issuable in this program (at $0.1259) bringing total shares to 96,789,215. Management plans a 1‑for‑20 reverse stock split to address Nasdaq’s $1.00 minimum bid requirement.
The company highlights significant outstanding convertible notes, warrants and equity awards, plus recent financings including insider loans from NLabs, note conversions into preferred stock and common shares, a White Lion convertible note facility, and a secured term loan facility of up to $10,550,000. Proceeds from the ATM are earmarked for R&D, sales and marketing, and general corporate purposes, with acknowledged dilution risk to new investors.
Veea Inc. describes updates to its financing arrangements with White Lion Capital LLC. Under a previously agreed Note Purchase Agreement for up to $2,500,000 of unsecured Convertible Notes and related warrants, the company completed four closings, each issuing a Convertible Note with a face amount of $555,556. Earlier closings also included warrants, such as a First Warrant to purchase 990,099 shares of common stock at an exercise price of $0.505 per share, and additional warrants sized by dividing $500,000 by the closing price of the common stock at the time.
On August 10, 2026, Veea and White Lion entered into an Amendment, Waiver and Warrant Cancellation Agreement. The First, Second and Third Warrants, covering an aggregate of 2,612,822 shares, were cancelled in connection with a regular purchase notice under the existing equity line of credit. White Lion waived rights to receive warrants at the fourth closing and any rights to a fifth closing, and the deadline for stockholder approval tied to the Note Purchase Agreement was moved to September 30, 2026. White Lion also waived its rights in connection with an at-the-market offering under Veea’s Form S-3, while Veea agreed to use commercially reasonable efforts to include White Lion’s registrable securities in its next Form S-3 registration.
Veea Inc. entered into two unsecured demand promissory notes with principal stockholder NLabs Inc., an affiliate of its Chief Executive Officer. NLabs lent $500,000 on July 30, 2026 and $100,000 on July 31, 2026. Each note bears interest at an annual rate of 10%, calculated on a 365‑day year, and is payable, together with accrued interest, upon the earlier of December 31, 2026 and demand by NLabs. Veea may prepay the notes at any time without penalty, and the proceeds are designated for working capital purposes.
The board approved the termination, without cause, of Chief Financial Officer and Senior Vice President Randal Stephenson, effective July 31, 2026, and Veea and Mr. Stephenson are negotiating a termination and severance agreement to be disclosed and filed once completed. The board also appointed Greg Deisher, the company’s Chief Operating Officer and Executive Vice President, to serve as Acting Chief Financial Officer effective July 31, 2026, while he continues in his existing roles. Veea states that Mr. Deisher is a certified public accountant with more than 20 years of senior financial and operational experience and no disclosable related‑party relationships or selection arrangements.